Prediction and Validation of Metabolic Dysfunction-Associated Fatty Liver Disease Using Insulin Resistance-Related Indices in the Japanese Population

被引:0
|
作者
Moriyama, Kengo [1 ]
Inoue, Nagamu [1 ]
Imai, Jin [2 ]
Masuda, Yumi [3 ]
Yamada, Chizumi [3 ]
Kishimoto, Noriaki [3 ]
Takashimizu, Shinji [2 ]
Kubo, Akira [3 ]
Nishizaki, Yasuhiro [2 ]
机构
[1] Tokai Univ, Hachioji Hosp, Dept Clin Hlth Sci, Sch Med, Tokyo, Japan
[2] Tokai Univ, Dept Clin Hlth Sci, Sch Med, Hiratsuka, Kanagawa, Japan
[3] Tokai Univ, Sch Med, Dept Clin Hlth Sci, Tokyo Hosp, Tokyo, Japan
基金
日本学术振兴会;
关键词
metabolic dysfunction-associated fatty liver disease; triglyceride to high-density lipoprotein cholesterol ratio; alanine aminotransferase; insulin resistance; triglyceride-glucose index; annual health examination; HOMEOSTASIS MODEL ASSESSMENT; TRIGLYCERIDE-GLUCOSE INDEX; ETHNIC-DIFFERENCES; MANAGEMENT; PRODUCT;
D O I
10.1089/met.2023.0116
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Recently, metabolic dysfunction-associated fatty liver disease (MAFLD), which is based on evidence of hepatic steatosis and any of the following three conditions: overweight/obesity, presence of type 2 diabetes mellitus, or evidence of metabolic dysregulation, has been proposed. It is uncertain how indices that predict insulin resistance (IR) are associated with MAFLD. Methods: Among subjects who had undergone health examinations at our hospital, 1,257 (787 men and 474 women) who underwent fatty liver evaluation, were included in this cross-sectional study. The discriminatory ability of each index for MAFLD was tested using a receiver operating characteristic curve analysis. The associations between the homeostasis model assessment-IR (HOMA-IR), triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio, triglyceride-glucose (TyG) index, and MAFLD were investigated using multiple logistic regression analysis. Results: The mean age and body mass index of MAFLD subjects were 58.1 years and 26.0kg/m(2) in men and 63.0 years and 26.1kg/m(2) in women, respectively. The cutoff values of HOMA-IR, TG/HDL-C ratio, and TyG index in men and women were 1.40 (area under the curve [AUC]: 0.81) and 1.90 (AUC: 0.88); 1.56 (AUC: 0.75) and 1.06 (AUC: 0.78); and 8.62 (AUC: 0.75) and 8.45 (AUC: 0.80), respectively. All indices were significantly higher in both men and women with MAFLD. In the multivariate models, the odds of MAFLD were higher among both men and women in the highest tertile than those in the lowest tertile. When subjects were divided by sex, presence of MAFLD, and alanine aminotransferase (ALT) values, all indices were significantly higher in both men and women with high ALT levels who were diagnosed with MAFLD. Conclusion: IR strongly correlated with MAFLD, particularly in subjects with high ALT levels.
引用
收藏
页码:489 / 496
页数:8
相关论文
共 50 条
  • [21] Validation of a screening panel for pediatric metabolic dysfunction-associated steatotic liver disease using metabolomics
    Huneault, Helaina E.
    Gent, Alasdair E.
    Cohen, Catherine C.
    He, Zhulin
    Jarrell, Zachery R.
    Kamaleswaran, Rishikesan
    Vos, Miriam B.
    HEPATOLOGY COMMUNICATIONS, 2024, 8 (03)
  • [22] Association of Stroke With Metabolic Dysfunction-Associated Fatty Liver Disease With and Without CKD
    Li, Yuhao
    Wu, Shouling
    Gao, Jingli
    Zhang, Yijun
    Zuo, Yingting
    Tian, Xue
    Chen, Shuohua
    Xing, Aijun
    Wang, Anxin
    He, Yan
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2024, 83 (04) : 477 - 488
  • [23] Metabolic dysfunction-associated fatty liver disease: advances in genetic and epigenetic implications
    Pirola, Carlos J.
    Sookoian, Silvia
    CURRENT OPINION IN LIPIDOLOGY, 2022, 33 (02) : 95 - 102
  • [24] Vitamin D and Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD): An Update
    Barchetta, Ilaria
    Cimini, Flavia Agata
    Cavallo, Maria Gisella
    NUTRIENTS, 2020, 12 (11) : 1 - 14
  • [25] Metabolic dysfunction-associated fatty liver disease and implications for cardiovascular risk and disease prevention
    Zhou, Xiao-Dong
    Cai, Jingjing
    Targher, Giovanni
    Byrne, Christopher D.
    Shapiro, Michael D.
    Sung, Ki-Chul
    Somers, Virend K.
    Chahal, C. Anwar A.
    George, Jacob
    Chen, Li-Li
    Zhou, Yong
    Zheng, Ming-Hua
    CARDIOVASCULAR DIABETOLOGY, 2022, 21 (01)
  • [26] An international multidisciplinary consensus on pediatric metabolic dysfunction-associated fatty liver disease
    Zhang, Le
    El-Shabrawi, Mortada
    Baur, Louise A.
    Byrne, Christopher D.
    Targher, Giovanni
    Kehar, Mohit
    Porta, Gilda
    Lee, Way Seah
    Lefere, Sander
    Turan, Serap
    Alisi, Anna
    Weiss, Ram
    Faienza, Maria Felicia
    Ashraf, Ambika
    Sundaram, Shikha S.
    Srivastava, Anshu
    De Bruyne, Ruth
    Kang, Yunkoo
    Bacopoulou, Flora
    Zhou, Yong-Hai
    Darma, Andy
    Lupsor-Platon, Monica
    Hamaguchi, Masahide
    Misra, Anoop
    Mendez-Sanchez, Nahum
    Ng, Nicholas Beng Hui
    Marcus, Claude
    Staiano, Amanda E.
    Waheed, Nadia
    Alqahtani, Saleh A.
    Giannini, Cosimo
    Ocama, Ponsiano
    Nguyen, Mindie H.
    Arias-Loste, Maria Teresa
    Ahmed, Mohamed Rabea
    Sebastiani, Giada
    Poovorawan, Yong
    Al Mahtab, Mamun
    Pericas, Juan M.
    da Silveira, Themis Reverbel
    Hegyi, Peter
    Azaz, Amer
    Isa, Hasan M.
    Lertudomphonwanit, Chatmanee
    Farrag, Mona Issa
    Nugud, Ahmed Abd Alwahab
    Du, Hong-Wei
    Qi, Ke-Min
    Mouane, Nezha
    Cheng, Xin-Ran
    MED, 2024, 5 (07): : 797 - +
  • [27] LIVERSTAT for risk stratification for patients with metabolic dysfunction-associated fatty liver disease
    Leow, Yong Wen
    Chan, Wah Loong
    Lai, Lee Lee
    Mustapha, Nik Raihan Nik
    Mahadeva, Sanjiv
    Quiambao, Ronald
    Munteanu, Mona
    Chan, Wah Kheong
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 (10) : 2182 - 2189
  • [28] Associations between metabolic dysfunction-associated fatty liver disease and atherosclerotic cardiovascular disease
    Wen, Wen
    Fan, Hua
    Zhang, Shenghui
    Hu, Siqi
    Chen, Chen
    Tang, Jiake
    You, Yao
    Wang, Chunyi
    Li, Jie
    Luo, Lin
    Cheng, Yongran
    Zhou, Mengyun
    Zhao, Xuezhi
    Tan, Tao
    Xu, Fangfang
    Fu, Xinyan
    Chen, Juan
    Dong, Peng
    Zhang, Xingwei
    Wang, Mingwei
    Feng, Yan
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2024, 368 (06) : 557 - 568
  • [29] Comparison of the diagnostic performance of twelve noninvasive scores of metabolic dysfunction-associated fatty liver disease
    Zou, Haoxuan
    Ma, Xiaopu
    Zhang, Fan
    Xie, Yan
    LIPIDS IN HEALTH AND DISEASE, 2023, 22 (01)
  • [30] Metabolic dysfunction-associated fatty liver disease and osteoporosis: the mechanisms and roles of adiposity
    Tao, Jie
    Li, Hong
    Wang, Honggang
    Tan, Juan
    Yang, Xiaozhong
    OSTEOPOROSIS INTERNATIONAL, 2024, 35 (12) : 2087 - 2098